the following: (a) diagnosis of AD made on the basis of the DSM-IV criteria; (b) absence of nosographically defined syndromes, such as phenylketonuria, Down syndrome, muscular dystrophy, or fragile X syndrome; (c) absence of complex epileptic syndrome refractory to medication; and (d) age under 11 years. According to such criteria, we selected 77 children, 65 boys and 12 girls, aged between 2.5 and 10.7 years (mean, 5.3 years).
The study also included a control group composed of 32 nonautistic children, matched for age, gender and socio-economic level.
Clinical evaluation
Cognitive development, autistic symptomatology, and adaptive behavior were evaluated, respectively, with Griffiths' scales [5] and Wechsler intelligence scale for children (WISC-R) [6] , childhood autism rating scale (CARS) [7] , and Vineland adaptive behavior scales (ABS) [8] . Each child was monitored with a videotaped play session, standardized for time, materials, and type of interaction.
Reports of each child's behavior were obtained through a structured interview with the child's parent. The interview concerned the following areas: psychomotor development, age and pattern of onset of the autistic symptomatology, environmental factors, and the child's actual behaviors, especially as related to pain reactivity.
All children were evaluated clinically with electroencephalography (EEG), brain imaging, auditory brainstem response (ABR), screening test for inborn errors of metabolism, and karyotype determination. Other instrumental or laboratory examinations were performed on the basis of the clinical findings.
In 44 of the 77 children, serotonin blood levels were measured. Blood samples were centrifuged for 25 min at 4°C at 140 x g within 20 min after venipuncture, according to standard protocols [9] . One milliliter supernatant phase, the platelet-rich plasma (PRP), was stored at -80°C and assessed by high-performance liquid chromatography (HPLC), as previously described [10, 11] . These 44 subjects were included in a multicentric study on genetic aspects of autism, coordinated by the Laboratory of Neuroscience, Libera Università Campus Bio-Medico, Rome, Italy.
Pain reactivity evaluation
Information on each child's behavior related to pain reactivity was obtained during the structured interview. If the parent reported an abnormal reaction to nociceptive stimuli, the interviewer asked a series of follow-up questions. The follow-up questions were designed to obtain more detailed information about the frequency of the abnormal reactions (sometimes or always), the kind of stimuli in which the child showed "analgesia" (i.e. accidental trauma, medical interventions, trauma caused by other children), and the situation in which the abnormal reaction occurred (at home, at school, etc.).
The behaviors described in the parents' answers were coded into categories after the completion of the data collection. The categories were the following:
1. Normal pain reactivity (NPR). No abnormal reactions were described; 2. Low pain reactivity (LPR). Abnormal reaction to pain was discontinuous or related to a particular stimulus or situation; 3. Very low pain reactivity (VLPR). Abnormal reactions were constant regardless of the kind of stimulus and situations. The interview was also carried out with the parents of the 32 non-autistic children in the control group.
Statistical analysis
The probability level (p value) was evaluated by Student's t statistics, χ 2 test, and regression analysis.
Results
In autistic children, the pain reactivity was low (LPR) in 22% and very low (VLPR) in 21%. The percentages of LPR and VLPR in the control group were, respectively, 7% and 3% (χ 2 = 11.550; p < .005) ( Table 1) .
For autistic children, we examined the relationship between pain reactivity and the following variables: age, development quotient (DQ), CARS score, Vineland ABS score, and serotoninemia (Table 2) . No significant correlation was observed, except for serotoninemia (r = .329; p < .05). The difference in blood serotonin levels between the NPR and VLPR groups was statistically significant (t = 2.220; df = 32; p < .05).
Discussion
The results of the present study suggest an abnormal pain reactivity in children with autistic disorder when compared with nonautistic children. However, great caution is necessary in interpreting this finding [12] . We can only refer to parents' impressions. The age of the children and the nature of the disorder make it difficult to measure the pain thresh- Table 1 Frequency distribution of pain reactivities determined from the structured interview with parents, by study group old. A communication disorder does not allow for checklist and self-reporting measures [13] . The abnormal reaction to body contact precludes using standardized situations, such as intramuscular injections or venipuncture for medical purposes [14] , because an autistic child can have violent panic attacks just when touched. Furthermore, the faces pain scale [13, 15] is useless because a child with autistic disorder typically shows poor modulation of the emotions with inappropriate body expressions. In spite of these methodological limitations, abnormal pain reactivity is an interesting feature because it may represent the clinical expression of neurochemical dysfunctions reported in autism. For example, a significant correlation between pain reactivity and serotoninemia was found. This finding has never been reported in studies regarding autism. Interestingly, the association between serotoninemia and pain threshold was also found in subjects with temporomandibular joint pain [16] [17] [18] . These findings fall within research on the key role of the serotoninergic system in the descending cortical control of nociceptive processing [19] .
The data obtained in our study are interesting, but must be considered with careful attention both for the sample size and for the methodological difficulties. In fact, in studying autistic children, only the parents' insight can be of help. 
